Skip to main content
. Author manuscript; available in PMC: 2019 Dec 15.
Published in final edited form as: Clin Cancer Res. 2018 Aug 14;24(24):6556–6569. doi: 10.1158/1078-0432.CCR-17-1679

Figure 2. Survival based on KMT2C mutation status and level of KMT2C protein expression.

Figure 2.

(A) Kaplan-Meier curve of recurrence-free survival based KMT2C mutation status. (B) Photos of tumors following immunohistochemical staining for KMT2C protein, and table demonstrating relationship between KMT2C mutation status and KMT2C protein expression by immunohistochemistry. Scale bar, 50 μm. Kaplan-Meier curves of recurrence-free survival (C) and overall survival (D) of 146 patients undergoing potentially curative gastric cancer resection stratified by low vs. high expression of KMT2C protein. FYRC pfama, F/Y rich C-terminusFYRC pfama, F/Y rich C-terminus